A detailed history of Manufacturers Life Insurance Company, The transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 8,594 shares of LGND stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,594
Previous 8,761 1.91%
Holding current value
$1.02 Million
Previous $738,000 16.53%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$82.7 - $110.11 $13,810 - $18,388
-167 Reduced 1.91%
8,594 $860,000
Q2 2024

Aug 14, 2024

BUY
$68.53 - $87.91 $27,891 - $35,779
407 Added 4.87%
8,761 $738,000
Q1 2024

May 14, 2024

BUY
$68.64 - $89.2 $6,177 - $8,028
90 Added 1.09%
8,354 $610,000
Q4 2023

Feb 13, 2024

SELL
$49.57 - $72.63 $13,780 - $20,191
-278 Reduced 3.25%
8,264 $590,000
Q3 2023

Nov 15, 2023

BUY
$58.86 - $72.67 $103,534 - $127,826
1,759 Added 25.93%
8,542 $511,000
Q2 2023

Aug 11, 2023

BUY
$69.53 - $79.33 $44,846 - $51,167
645 Added 10.51%
6,783 $489,000
Q1 2023

May 15, 2023

BUY
$65.67 - $77.08 $2,035 - $2,389
31 Added 0.51%
6,169 $453,000
Q4 2022

Aug 11, 2023

BUY
$61.72 - $96.74 $6,357 - $9,964
103 Added 1.71%
6,138 $410,000
Q4 2022

Feb 13, 2023

BUY
$61.72 - $96.74 $6,357 - $9,964
103 Added 1.71%
6,138 $410,000
Q3 2022

Aug 11, 2023

SELL
$0.01 - $107.56 $0 - $10,218
-95 Reduced 1.55%
6,035 $519,000
Q3 2022

Nov 03, 2022

SELL
$0.01 - $107.56 $0 - $10,218
-95 Reduced 1.55%
6,035 $520,000
Q2 2022

Aug 11, 2023

SELL
$74.52 - $117.06 $9,315 - $14,632
-125 Reduced 2.0%
6,130 $546,000
Q2 2022

Aug 15, 2022

SELL
$74.52 - $117.06 $9,315 - $14,632
-125 Reduced 2.0%
6,130 $547,000
Q1 2022

Aug 11, 2023

BUY
$94.99 - $151.56 $8,169 - $13,034
86 Added 1.39%
6,255 $703,000
Q1 2022

May 20, 2022

SELL
$94.99 - $151.56 $132,891 - $212,032
-1,399 Reduced 18.28%
6,255 $704,000
Q4 2021

Feb 16, 2022

SELL
$127.69 - $165.85 $31,922 - $41,462
-250 Reduced 3.16%
7,654 $1.18 Million
Q3 2021

Nov 12, 2021

SELL
$102.33 - $144.73 $1.89 Million - $2.68 Million
-18,513 Reduced 70.08%
7,904 $1.1 Million
Q2 2021

Aug 12, 2021

SELL
$113.03 - $155.64 $6,216 - $8,560
-55 Reduced 0.21%
26,417 $3.47 Million
Q1 2021

May 03, 2021

SELL
$99.52 - $215.83 $12.9 Million - $28 Million
-129,837 Reduced 83.06%
26,472 $4.04 Million
Q4 2020

Feb 12, 2021

BUY
$80.55 - $106.05 $2.07 Million - $2.72 Million
25,649 Added 19.63%
156,309 $15.5 Million
Q3 2020

Nov 09, 2020

BUY
$89.56 - $126.72 $555,092 - $785,410
6,198 Added 4.98%
130,660 $12.5 Million
Q2 2020

Aug 10, 2020

SELL
$68.28 - $123.65 $343,926 - $622,825
-5,037 Reduced 3.89%
124,462 $14.1 Million
Q1 2020

May 15, 2020

SELL
$63.37 - $107.88 $16.3 Million - $27.7 Million
-256,832 Reduced 66.48%
129,499 $9.42 Million
Q4 2019

Feb 14, 2020

SELL
$96.94 - $113.59 $25,882 - $30,328
-267 Reduced 0.07%
386,331 $40.3 Million
Q3 2019

Nov 12, 2019

SELL
$86.25 - $120.16 $6.3 Million - $8.78 Million
-73,096 Reduced 15.9%
386,598 $38.3 Million
Q2 2019

Aug 14, 2019

SELL
$107.38 - $129.34 $10.5 Million - $12.7 Million
-97,818 Reduced 17.55%
459,694 $52.5 Million
Q1 2019

May 13, 2019

BUY
$105.93 - $142.47 $16.2 Million - $21.7 Million
152,649 Added 37.7%
557,512 $70.1 Million
Q4 2018

Feb 14, 2019

BUY
$128.36 - $272.13 $8.27 Million - $17.5 Million
64,400 Added 18.92%
404,863 $54.9 Million
Q3 2018

Nov 14, 2018

SELL
$211.18 - $274.49 $402,509 - $523,177
-1,906 Reduced 0.56%
340,463 $93.5 Million
Q2 2018

Aug 14, 2018

BUY
$150.77 - $207.98 $49.3 Million - $68.1 Million
327,215 Added 2159.26%
342,369 $70.9 Million
Q1 2018

May 15, 2018

SELL
$138.63 - $182.62 $60,165 - $79,257
-434 Reduced 2.78%
15,154 $2.5 Million
Q4 2017

Feb 08, 2018

BUY
$128.36 - $147.04 $20,409 - $23,379
159 Added 1.03%
15,588 $2.13 Million
Q3 2017

Nov 14, 2017

BUY
$120.91 - $137.94 $1.87 Million - $2.13 Million
15,429
15,429 $2.1 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.01B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.